Pregled bibliografske jedinice broj: 278495
Safety and immunogenicity of Poxvirus - H5 AI recombinant vaccine delivered to newly-hatched chickens by nebulisation
Safety and immunogenicity of Poxvirus - H5 AI recombinant vaccine delivered to newly-hatched chickens by nebulisation // World's Poultry Science Journal / Romboli, I ; Flock, D ; Franchini, A (ur.).
Beekbergen: Personal Media Solutions B.V., 2006. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 278495 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Safety and immunogenicity of Poxvirus - H5 AI recombinant vaccine delivered to newly-hatched chickens by nebulisation
Autori
Mazija, Hrvoje ; Gottstein, Željko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
World's Poultry Science Journal
/ Romboli, I ; Flock, D ; Franchini, A - Beekbergen : Personal Media Solutions B.V., 2006
Skup
XII European Poultry Conference
Mjesto i datum
Verona, Italija, 10.09.2006. - 14.09.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
chickens; recombinant vaccine; nebulisation; Poxvirus; Influenzavirus
Sažetak
Based on a preliminary research which proved safety and immunogenicity of Poxvirus vaccines (fowl origin) delivered by nebulisation, newly-hatched chickens were vaccinated with Poxvirus-H5 AI recombinant commercial vaccine. The vaccine given by nebulisation proved to be safe when applied during 30 and 300 seconds and none of the chickens in the trial showed any clinical signs from the respiratory or any other system. Vaccine virus was detected in the trachea and lungs of nebulised chickens already 20 hours after vaccination using specific primers by PCR reaction, but was not present in the bone marrow or other tissues. Persistency and level of specific protection against Poxvirus and Influenzavirus are still under investigation.
Izvorni jezik
Engleski
Znanstvena područja
Veterinarska medicina
